We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+12.53%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$21.3B
AUM Growth
+$4.08B
(+24%)
Cap. Flow
+$2.12B
Cap. Flow
% of AUM
9.98%
Top 10 Holdings %
Top 10 Hldgs %
58.73%
Holding
1,162
New
154
Increased
426
Reduced
439
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MPLX
MPLX
|
+$1.51B |
| 2 |
Western Midstream Partners
WES
|
+$147M |
| 3 |
NexGen Energy
NXE
|
+$124M |
| 4 |
Eaton Vance Total Return Bond ETF
EVTR
|
+$52.4M |
| 5 |
Freeport-McMoran
FCX
|
+$51.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uranium Energy
UEC
|
+$123M |
| 2 |
Plains All American Pipeline
PAA
|
+$59.9M |
| 3 |
AngloGold Ashanti
AU
|
+$35.3M |
| 4 |
Royal Gold
RGLD
|
+$30.5M |
| 5 |
Harmony Gold Mining
HMY
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 68.07% |
| 2 | Materials | 6.1% |
| 3 | Technology | 3.07% |
| 4 | Financials | 2.69% |
| 5 | Utilities | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
BioCryst Pharmaceuticals
BCRX
$2.37B
| $574K | ﹤0.01% |
+60,250
| New | +$468K |
|
677
Grupo Aeroportuario del Sureste
ASR
$8.03B
| $572K | ﹤0.01% |
1,703
+55
| +3% | +$18.8K |
|
678
Alto Neuroscience
ANRO
$1.04B
| $568K | ﹤0.01% |
25,288
-217
| -0.9% | -$4.02K |
|
679
Arrowhead Research
ARWR
$12.1B
| $564K | ﹤0.01% |
+9,000
| New | +$570K |
|
680
Delta Air Lines
DAL
$55.9B
| $560K | ﹤0.01% |
8,422
+725
| +9% | +$48.8K |
|
681
Marvell Technology
MRVL
$174B
| $559K | ﹤0.01% |
+5,640
| New | +$474K |
|
682
Virtu Financial
VIRT
$5.2B
| $557K | ﹤0.01% |
12,667
+114
| +0.9% | +$4.44K |
|
683
Nabors Industries
NBR
$1.23B
| $557K | ﹤0.01% |
+6,470
| New | +$469K |
|
684
Phibro Animal Health
PAHC
$1.38B
| $554K | ﹤0.01% |
+10,010
| New | +$476K |
|
685
Abercrombie & Fitch
ANF
$4.17B
| $553K | ﹤0.01% |
6,053
+795
| +15% | +$77.3K |
|
686
Iridium Communications
IRDM
$4.85B
| $553K | ﹤0.01% |
+19,920
| New | +$448K |
|
687
GigaCloud Technology
GCT
$1.35B
| $549K | ﹤0.01% |
12,097
-3,318
| -22% | -$135K |
|
688
Casey's General Stores
CASY
$31.9B
| $549K | ﹤0.01% |
754
-75
| -9% | -$48.9K |
|
689
International Seaways
INSW
$4.57B
| $547K | ﹤0.01% |
+7,510
| New | +$480K |
|
690
United Therapeutics
UTHR
$26.3B
| $546K | ﹤0.01% |
921
-210
| -19% | -$105K |
|
691
Burlington
BURL
$22B
| $545K | ﹤0.01% |
1,674
-35
| -2% | -$10.7K |
|
692
TechnipFMC
FTI
$30.6B
| $543K | ﹤0.01% |
7,858
-3,681
| -32% | -$221K |
|
693
United States Lime & Minerals
USLM
$3.18B
| $543K | ﹤0.01% |
4,158
+530
| +15% | +$63.7K |
|
694
Carpenter Technology
CRS
$30B
| $541K | ﹤0.01% |
1,373
-545
| -28% | -$199K |
|
|
CTRA
695
DELISTED
Coterra Energy
CTRA
| $541K | ﹤0.01% |
+15,400
| New | +$463K |
|
696
Weatherford International
WFRD
$6.36B
| $541K | ﹤0.01% |
5,720
-1,661
| -23% | -$156K |
|
697
ANI Pharmaceuticals
ANIP
$1.77B
| $541K | ﹤0.01% |
+7,030
| New | +$549K |
|
698
Analog Devices
ADI
$181B
| $541K | ﹤0.01% |
1,699
-172
| -9% | -$54.7K |
|
699
Tidewater
TDW
$3.91B
| $539K | ﹤0.01% |
6,456
-1,330
| -17% | -$92.5K |
|
700
Clear Secure
YOU
$5.26B
| $537K | ﹤0.01% |
11,096
-1,248
| -10% | -$49.7K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, ALPS Advisors held 1,162 positions worth $21.3B, up 24% from $17.2B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
ALPS Advisors deployed $2.12B of net new capital in Q1 2026, opening 154 new positions and adding to 426 existing holdings. Its largest new stake was Eaton Vance Total Return Bond ETF: 1,017,240 shares worth $51.6M.
By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 63% a quarter earlier, followed by Materials and Technology.
On the sell side, the largest reduction was Uranium Energy, an estimated $123M trimmed.
- ALPS Advisors's largest Q1 2026 buy was Eaton Vance Total Return Bond ETF: 1,017,240 shares worth $51.6M.
- ALPS Advisors added most to MPLX in Q1 2026, an estimated $1.51B increase.
- ALPS Advisors's biggest Q1 2026 reduction was Uranium Energy, cutting an estimated $123M.
- ALPS Advisors fully exited Columbia EM Core ex-China ETF in Q1 2026, selling an estimated $15.5M.
- ALPS Advisors's ten largest holdings make up 59% of its $21.3B portfolio in Q1 2026.
- ALPS Advisors opened 154 new positions and closed 125 in Q1 2026.
- ALPS Advisors's portfolio value rose 24% quarter-over-quarter to $21.3B.
Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.